Showing results (41-50 of 103) with videos related to
Sort By:
Pageof 11
Ophthalmology|December 20, 2005
Incidence of intraocular pressure spike and other adverse events after vitreoretinal surgeryNicholas G Anderson, Mitchell S Fineman, Gary C BrownAmerican Journal of Ophthalmology|March 11, 2008
A value-based medicine cost-utility analysis of idiopathic epiretinal membrane surgeryOmesh P Gupta, Gary C Brown, Melissa M BrownCurrent Opinion in Ophthalmology|April 17, 2007
Age-related macular degeneration: the costs to society and the patientOmesh P Gupta, Gary C Brown, Melissa M BrownOphthalmic Surgery, Lasers & Imaging Retina|February 24, 2015
Neovascular age-related macular degeneration associated with no light perceptionGary C Brown, Mahdi M Basha, Melissa M BrownSurvey of Ophthalmology|April 11, 2003
Health care economic analyses and value-based medicineMelissa M Brown, Gary C Brown, Sanjay Sharma, et al.American Journal of Ophthalmology|June 23, 2020
Cost-Utility Analysis of VEGF Inhibitors for Treating Neovascular Age-Related Macular DegenerationGary C Brown, Melissa M Brown, Sara Rapuano, et al.Ophthalmology|June 12, 2003
Quality of life associated with visual loss: a time tradeoff utility analysis comparison with medical health statesMelissa M Brown, Gary C Brown, Sanjay Sharma, et al.Ophthalmology|May 4, 2015
The Cost-Effectiveness of Ranibizumab for the Treatment of Diabetic Macular EdemaGary C Brown, Melissa M Brown, Adam Turpcu, et al.Current Opinion in Ophthalmology|May 9, 2009
Comparative effectiveness: its role in the healthcare systemMelissa M Brown, Betsy Luo, Heidi C Brown, et al.Current Opinion in Ophthalmology|April 17, 2007
Pharmacoeconomics and macular degenerationGary C Brown, Melissa M Brown, Heidi Brown, et al.Pageof 11